Oncology : ALBA
Oncology : Elekta
Proton therapy
Comparison of dose distributions between X-ray therapy (left) and proton therapy (right)
Rtsafe
RTsafe introduces the new generation of 3D printed dosimetry phantoms
As radiation therapy becomes even more customizable to each individual patient, the complexities of the supporting treatment planning system (TPS) and the dose delivery system increase. This in turn, requires a constant evolution of quality assurance (QA) methods used to verify the performance of the systems and to implement reliable End-to-End QA and plan/treatment verification in clinical practice.
RTsafe is a medical technology company that has developed a unique approach to quality assurance that significantly enhances the safety and accuracy of radiotherapy for cancer and other medical conditions. It combines proven expertise in medical physics with highly accurate 3D printing technology to create pseudo‐in‐vivo dosimetry phantoms towards End‐to‐End commissioning, benchmarking and patient‐specific quality assurance in SRS, IMRT, VMAT and SBRT applications. The anatomically accurate effigies enable medical professionals to plan more precise treatment interventions for each individual patient and help radiotherapy technology innovators to fine‐tune their products. The result is more effective individualized therapy and reduced patient risk.
RTsafe introduces the new generation of 3D printed dosimetry phantoms
As radiation therapy becomes even more customizable to each individual patient, the complexities of the supporting treatment planning system (TPS) and the dose delivery system increase. This in turn, requires a constant evolution of quality assurance (QA) methods used to verify the performance of the systems and to implement reliable End-to-End QA and plan/treatment verification in clinical practice.